Clinical research

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial

EuroIntervention 2013;9:75-83. DOI: 10.4244/EIJV9I1A12

Run-Lin Gao
Run-Lin Gao1*, MD; Bo Xu1, MBBS; Alexandra J. Lansky2, MD; Yue-Jin Yang1, MD; Chang-Sheng Ma3, MD; Ya-Ling Han4, MD; Shao-Liang Chen5, MD; Hui Li6, MD; Rui-Yan Zhang7, MD; Guo-Sheng Fu8, MD; Zu-Yi Yuan9, MD; Hong Jiang10, MD; Yong Huo11, MD; Wei Li1, PhD; Yao-Jun Zhang5, MD; Martin B. Leon12, MD; on behalf of the TARGET I Investigators
1. Fu Wai Hospital, National Center for Cardiovascular Diseases of China, Beijing, China; 2. Yale University School of Medicine, New Haven, CT, USA; 3. Affiliated An zhen Hospital of Capital Medical University, Beijing, China; 4. Shenya

Aims: The study sought to evaluate the safety and efficacy of FIREHAWK, a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent (SES) for treating patients with

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

biodegradable polymerclinical researcheverolimus-eluting stentfirehawklate lumen loss
Read next article
Acute outcomes after MitraClip® therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry

Latest news